- Home
- IVDA vs APVO Comparison
IVDA vs APVO Comparison
Compare IVDA & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- APVO
- Stock Information
- Founded
- IVDA 2003
- APVO 2016
- Country
- IVDA United States
- APVO United States
- Employees
- IVDA N/A
- APVO N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- APVO Health Care
- Exchange
- IVDA Nasdaq
- APVO Nasdaq
- Market Cap
- IVDA 4.3M
- APVO 4.1M
- IPO Year
- IVDA N/A
- APVO N/A
- Fundamental
- Price
- IVDA $1.47
- APVO $1.61
- Analyst Decision
- IVDA
- APVO Strong Buy
- Analyst Count
- IVDA 0
- APVO 1
- Target Price
- IVDA N/A
- APVO $5,920.00
- AVG Volume (30 Days)
- IVDA 222.6K
- APVO 162.7K
- Earning Date
- IVDA 08-14-2025
- APVO 11-06-2025
- Dividend Yield
- IVDA N/A
- APVO N/A
- EPS Growth
- IVDA N/A
- APVO N/A
- EPS
- IVDA N/A
- APVO N/A
- Revenue
- IVDA $7,142,302.00
- APVO N/A
- Revenue This Year
- IVDA $340.48
- APVO N/A
- Revenue Next Year
- IVDA N/A
- APVO N/A
- P/E Ratio
- IVDA N/A
- APVO N/A
- Revenue Growth
- IVDA 88.96
- APVO N/A
- 52 Week Low
- IVDA $1.27
- APVO $1.54
- 52 Week High
- IVDA $8.05
- APVO $381.10
- Technical
- Relative Strength Index (RSI)
- IVDA 33.87
- APVO 28.32
- Support Level
- IVDA $1.44
- APVO $1.56
- Resistance Level
- IVDA $1.68
- APVO $1.73
- Average True Range (ATR)
- IVDA 0.13
- APVO 0.14
- MACD
- IVDA -0.00
- APVO 0.02
- Stochastic Oscillator
- IVDA 10.42
- APVO 11.29
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.